Australia is welcome potentially transformative therapy for obesity: Retatrutide. This dual molecule – acting on both GLP-1 and GIP receptors – Retatrutide Australia Treatments shows promising outcomes in global research, pointing to substantial reductions in body fat. While approval is pending with Australian regulators, many Australians strug